| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Nov―21 |
Significance of certain leukocyte indices in patients with type 2 diabetes who have had novel coronavirus infection |
S. A. Sukhanov, Yu. A. Sorokina, O. V. Zanozina, A. A. Mosinа, I. D. Kapranova |
| 2 |
[GO] |
2025―Sep―10 |
The role of acute respiratory distress syndrome in the adverse outcomes of acute myocardial infarction in patients with SARS-CoV-2 pneumonia on the background of comorbid pathology |
M. V. Mayer, F. A. Talibov, T. I. Makeeva, E. V. Zbyshevskaya, E. N. Gnevyshev, E V. Yakovlev, D. Y. Butko |
| 3 |
[GO] |
2025―Sep―10 |
The impact of chronic obstructive pulmonary disease on the dynamics of clinical manifestations in severe COVID-19 |
V. V. Gaynitdinova, T. Yu. Gneusheva, R. M. Aynetdinov, Huixin Wang, A. A. Khanova, S. N. Avdeev |
| 4 |
[GO] |
2025―May―13 |
Non-invasive ventilation in acute respiratory failure in patients with coronavirus infection at the pre-resuscitation stage |
Z. M. Merzhoeva, A. I. Yaroshetskiy, N. A. Tsareva, N. V. Trushenko, G. S. Nuralieva, V. V. Gaynitdinova, S. N. Avdeev |
| 5 |
[GO] |
2025―Jan―31 |
Thrombocytopenia in COVID-19 patients: The role of fondaparinux and succinates in improving outcomes (exchange of experience) |
N. Yu. Semigolovskii, V. A. Ratnikov, I. S. Simutis, A. V. Svetlikov, L. G. Ermolaeva, D. S. Salygina, M. S. Danilov, S. N. Semigolovskii, A. A. Gorokhov, M. S. Mazurenko |
| 6 |
[GO] |
2024―Dec―12 |
Prediction of restrictive ventilation disorders after COVID-19 |
O. I. Savushkina, E. S. Muravyeva, S. N. Avdeev, A. A. Zaitsev, G. N. Nekludova, E. V. Kryukov |
| 7 |
[GO] |
2024―Dec―12 |
The role of pulmonary surfactant in the pathogenesis of bronchopulmonary diseases and the prospects of surfactant therapy in COVID-19 |
I. V. Bliznova, L. N. Tolmacheva, M. S. Danilova, R. A. Bontsevich |
| 8 |
[GO] |
2024―Nov―12 |
The use of a heated helium-oxygen mixture in patients with severe COVID-19 and ARDS against the background of standard therapy and noninvasive ventilation |
G. S. Nuralieva, A. E. Shmidt, A. I. Yaroshetskiy, G. V. Nekludova, V. V. Gaynitdinova, N. A. Tsareva, Z. M. Merzhoeva, S. Yu. Chikina, N. V. Trushenko, I. S. Avdeev, S. N. Avdeev |
| 9 |
[GO] |
2024―Nov―08 |
Somatic and neurological comorbidities in COVID-19 with fatal outcome |
O. I. Ignatieva, A. V. Sergachev, V. F. Pavelkina, V. N. Ignatiev, A. A. Erovichenkov |
| 10 |
[GO] |
2024―Jun―10 |
The effect of levilimab on the clinical presentations and changes in inflammatory biomarkers in outpatients with mild to moderate COVID-19 |
T. N. Nizhenko, E. V. Shikh, Zh. M. Sizova, V. N. Drozdov, N. I. Lapidus, A. E. Pakhomova |
| 11 |
[GO] |
2024―Jun―10 |
6-minute walk test in patients hospitalized with COVID-19 |
T. V. Kanaeva, N. A. Karoli |
| 12 |
[GO] |
2024―Jun―10 |
Incidence of coronavirus disease (COVID-19) in patients with different degrees of chronic rhinosinusitis with nasal polyps |
E. V. Lyubimova, E. L. Savlevich, A. V. Zurochka, E. S. Mitrofanova, O. M. Kurbacheva |
| 13 |
[GO] |
2024―Jun―10 |
Fatigue syndrome after COVID-19 infection: results of personal observations |
P. E. Kolesnikov, A. A. Vizel, A. R. Abashev, L. V. Davydova |
| 14 |
[GO] |
2024―May―22 |
Platelet link of hemostasis in polymorbid patients with acute coronary syndrome and COVID-19 |
L. I. Kadnikov, N. V. Izmozherova, A. A. Popov, I. P. Antropova |
| 15 |
[GO] |
2024―May―22 |
Information systems as a source of meaningful information in an epidemic: experience and lessons in restoring routine otorhinolaryngology care after the COVID-19 pandemic |
A. A. Korneenkov, P. A. Ovchinnikov, E. A. Vyazemskaya, A. Y. Medvedeva, Yu. K. Yanov |
| 16 |
[GO] |
2024―May―14 |
A case of granulomatos is with polyangiitis (Wegener’s) after a patient’s suffering from a new coronavirus infection COVID-19 |
M. A. Balaganskaya, S. N. Galkina, A. V. Teteneva, E. A. Starovoytova, N. A. Kirillova, T. V. Sorokina, N. Yu. Kolesnik, K. S. Sergeeva, T. A. Zagromova, S. V. Fedosenko |
| 17 |
[GO] |
2024―May―14 |
Clinical efficacy of various regimens of systemic glucocorticoids therapy in COVID-19 patients |
N. I. Voloshin, V. V. Salukhov, A. A. Minakov, M. O. Prokhorova, T. A. Belyakova, V. V. Kochukova |
| 18 |
[GO] |
2024―Apr―23 |
Surfactant protein D as a marker of persistent impairment of the lungs diffusion capacity in the long-term period in patients who had suffered from severe COVID-19 |
G. B. Abdullaeva, M. V. Kozhevnikova, D. S. Valiulina, Yu. N. Belenkov |
| 19 |
[GO] |
2024―Jan―22 |
The course of subacute thyroiditis from COVID-19 infection |
M. I. Strokova, T. B. Morgunova, V. V. Fadeev |
| 20 |
[GO] |
2024―Jan―22 |
Obstetric and perinatal outcomes after a new coronavirus infection in the first and second trimesters of pregnancy |
N. F. Khvorostukhina, D. I. Sheveleva, D. A. Novichkov, N. N. Stepanova, G. S. Suvorova, O. S. Odnokozova, Yu. K. Akhmedova |
| 21 |
[GO] |
2023―Dec―06 |
A clinical case of viral myocarditis associated with sars-cov-2 in a health worker |
S. A. Babanov, T. A. Azovskova, N. E. Lavrentyeva, R. A. Baraeva |
| 22 |
[GO] |
2023―Nov―21 |
Hypoxemia without dyspnea in COVID-19 |
D. V. Fan, G. V. Nekludova, Z. G.-M. Berikkhanov, S. N. Avdeev |
| 23 |
[GO] |
2023―Nov―21 |
Characteristics of patients with sarcoidosis who referred to a pulmonologist during the COVID-19 pandemic |
A. A. Vizel, I. Yu. Vizel, G. R. Shakirova, L. A. Vizel |
| 24 |
[GO] |
2023―Nov―21 |
Geography of patients in the federal ENT hospital before and after the COVID-19 pandemic: changing spatial patterns and characteristics |
A. A. Korneenkov, P. A. Ovchinnikov, E. E. Vyazemskaya, A. Yu. Medvedeva, Yu. K. Yanov |
| 25 |
[GO] |
2023―Nov―21 |
Difficulties in diagnosing complications of COVID-19: description of a clinical case |
E. V. Loshkova, M. V. Rebrienko, I. V. Doroshenko, T. S. Lyulka, A. V. Budkin, Yu. S. Rafikova, E. I. Kondratyeva, A. I. Khavkin, N. D. Odinaeva, A. L. Solnyshko, Е. V. Golikova |
| 26 |
[GO] |
2023―Nov―07 |
Characteristics of post COVID-19 condition in children after mild COVID-19 |
A. S. Chernyavskaya, O. I. Simonova, N. Yu. Kashirskaya |
| 27 |
[GO] |
2023―Nov―07 |
Influence of liver attenuation on the severity of course COVID-19: a retrospective cohort study |
Yu. F. Shumskaya, A. P. Gonchar, M. G. Mnatsakanyan, I. A. Blokhin, R. V. Reshetnikov, Yu. A. Vasilev |
| 28 |
[GO] |
2023―Oct―23 |
Cardiovascular complications in the context of COVID-19: arrhythmias |
A. S. Zmitrukevich, A. E. Mamedova, E. V. Reznik |
| 29 |
[GO] |
2023―Aug―22 |
Epidemiological analysis of systemic mycoses in COVID-19 |
A. V. Martynova, O. S. Pavlova, E. P. Yusupova |
| 30 |
[GO] |
2023―Aug―22 |
New coronavirus infection as a risk-factor for the development of tuberculosis: a clinical observation |
O. E. Russkikh, P. G. Sysoev, D. A. Kudlay |
| 31 |
[GO] |
2023―Aug―01 |
The impact of novel coronavirus infection and Sputnik V / Sputnik Light vaccination on menstrual function |
M. Yu. Fokina, A. E. Malikova, K. R. Bakhtiyarov |
| 32 |
[GO] |
2023―Jul―24 |
General infectious and neurological manifestations of new coronavirus infection COVID-19 |
O. I. Ignatieva, V. F. Pavelkina, V. N. Ignatiev, A. A. Erovichenkov |
| 33 |
[GO] |
2023―May―29 |
Hyperferritinemia, chronic hepatitis C and COVID-19: what do they have in common? |
M. I. Gonik, E. L. Bueverova, A. O. Bueverov |
| 34 |
[GO] |
2023―May―12 |
Assessment of working conditions and risks caused by the COVID-19 pandemic: results of an online survey of personnel of medical organizations |
A. A. Korneenkov, P. A. Ovchinnikov, E. E. Vyazemskaya, V. V. Dvoryanchikov, S. V. Ryazantsev, Yu. K. Yanov, I. V. Fanta |
| 35 |
[GO] |
2023―May―12 |
The effectiveness of a polyvalent antigenic complex including bacterial lysates in the treatment and prevention of rhinosinusitis against the background of acute respiratory viral infections and COVID-19 (clinical description) |
A. A. Krivopalov, S. V. Ryazantsev, Yu. S. Aleksanian, A. I. Glyshchenko |
| 36 |
[GO] |
2023―May―12 |
Glucocorticoids in the combination therapy of COVID-19 |
V. V. Skvortsov, A. V. Tumarenko, E. A. Malyakina, G. I. Maljakin |
| 37 |
[GO] |
2023―May―12 |
Comparative study of myocardial damage in hantavirus and new coronavirus infection |
G. A. Galieva, G. Kh. Mirsaeva, R. M. Fazlyeva, E. R. Kamaeva, O. L. Andrianova, D. I. Masalimova, A. Kh. Islamgulov, V. V. Nikulina, A. R. Imaeva |
| 38 |
[GO] |
2023―May―12 |
Possibilities of personalized pharmacotherapy and medical rehabilitation of patients with long COVID from the perspective of clinical metabolomics |
I. V. Kukes, V. G. Lim, K. A. Ivantsov, E. Yu. Solovyeva, L. P. Sokolova, I. R. Gilmutdinova, P. B. Glagovskiy, M. S. Ptitsyn |
| 39 |
[GO] |
2023―Apr―19 |
The use of inhaled tauractant therapy in the subacute period of COVID-19 |
O. O. Voronkova, A. A. Starzhevskaia, V. G. Skachek, E. F. Rogova, G. B. Abdullaeva, O. E. Buyanova, M. V. Kozhevnikova, Yu. N. Belenkov |
| 40 |
[GO] |
2023―Apr―19 |
Antibacterial therapy: questions posed by COVID-19 and real clinical practice |
A. A. Vizel, I. Yu. Vizel |
| 41 |
[GO] |
2023―Apr―19 |
Early distinctive clinical and hematological signs of hemorrhagic fever with renal syndrome and a new coronavirus infection occurring with lung damage |
G. A. Galieva, G. Kh. Mirsaeva, G. A. Mavzyutova, N. N. Mironchuk, L. Kh. Amineva, E. R. Kamaeva, T. N. Lisovskaya, A. R. Mukhetdinov |
| 42 |
[GO] |
2023―Apr―19 |
Experience of using systemic glucocorticoids during reconvalescence of patients after a new coronavirus infection of moderate severity |
Yu. V. Rudakov, A. A. Bogomolov, V. V. Salukhov, M. A. Kharitonov, A. A. Chugunov |
| 43 |
[GO] |
2023―Apr―18 |
Headaches associated with COVID-19 |
G. R. Tabeeva |
| 44 |
[GO] |
2023―Mar―17 |
The association of hair loss and coronavirus infection COVID-19 - facts and hypotheses |
I. O. Smirnova, O. M. Medetskaya, Ya. G. Petunova, P. D. Ptashnikova, N. V. Shin, A. O. Zhelonkina, A. R. Zhelonkin, O. N. Smirnova |
| 45 |
[GO] |
2023―Mar―14 |
Features of the treatment of children with mild asthma in the context of the COVID-19 pandemic |
T. N. Surovenko, E. F. Zhukalina, Iu. N. Krasnova |
| 46 |
[GO] |
2023―Mar―14 |
Quality of life in children after a new coronavirus infection |
E. P. Isaeva, O. V. Zaytseva, E. E. Lokshina, O. A. Murtazaeva, S. V. Zaytseva, N. A. Sirota, D. A. Ponkratov, I. V. Zyabkin |
| 47 |
[GO] |
2023―Jan―23 |
Analysis of severity and evaluation of prognosis in elderly patients with bronchial asthma and severe COVID-19 |
V. V. Gaynitdinova, S. N. Avdeev, A. A. Pozdniakova, A. E. Vlasenko, T. Yu. Gneusheva, K. A. Ter-Akopian, D. U. Allaberdina |
| 48 |
[GO] |
2023―Jan―23 |
Prospects for studying the role of some essential and toxic trace elements in the pathogenesis of COVID-19 |
O. O. Yanushevich, A. O. Romanov, M. V. Ivkina, A. N. Arkhangelskaia, M. M. Sharipova, M. V. Yakovleva, I. I. Shantyr, M. A. Vlasenko, K. G. Gurevich, O. V. Levchenko, I. V. Maev |
| 49 |
[GO] |
2023―Jan―23 |
Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19 |
I. I. Temirbulatov, A. V. Kryukov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, A. A. Kachanova, Zh. A. Sozaeva, A. S. Zhiryakova, Yu. V. Shevchuk, V. I. Vechorko, O. V. Averkov, D. A. Sychev |
| 50 |
[GO] |
2023―Jan―23 |
Patterns and features of the course of the early and late stages recovery period after ischemic stroke associated with COVID-19 |
E. N. Kabaeva, A. V. Ershov, P. F. Litvitskiy, D. T. Rejepov, A. A. Pozdnyakov |
| 51 |
[GO] |
2023―Jan―23 |
Features of the pathology of the lymphoid ring of the pharynx in children during the COVID-19 pandemic |
A. V. Andrianov, M. V. Drozdova, Yu. S. Preobrazhenskaya |
| 52 |
[GO] |
2023―Jan―23 |
Hospital readmissions of patients with COVID-19: causes, features, outcomes |
O. N. Potanina, S. A. Ayrapetyan, S. O. Mazurenko, V. V. Strizheletsky, L. S. Palchikova, N. A. Teplyakova, L. G. Ermolaeva, Iu. M. Gomon, N. Yu. Semigolovskii |
| 53 |
[GO] |
2023―Jan―23 |
A rational approach to drug therapy of acute bacterial sinusitis in patients who have had a coronavirus infection |
M. Yu. Korkmazov, N. V. Kornova, O. A. Gizinger, K. S. Zyryanova, A. S. Beloshangin |
| 54 |
[GO] |
2022―Nov―22 |
Local treatment of acute rhinosinusitis in the era of COVID-19 |
A. A. Krivopalov, S. V. Ryazantsev, V. V. Turieva |
| 55 |
[GO] |
2022―Nov―22 |
Orofacial and facial pain during the new coronavirus infection (COVID-19) pandemic. Choosing a non-steroid anti-inflammator - focus on nimesulide |
D. I. Trukhan, A. F. Sulimov, I. N. Stepanov, L. Yu. Trukhan, E. N. Degovtsov |
| 56 |
[GO] |
2022―Nov―16 |
Efficacy of dornase alfa as part of background therapy in children with cystic fibrosis during the COVID-19 pandemic |
O. I. Simonova, Yu. V. Gorinova, A. S. Chernyavskaya |
| 57 |
[GO] |
2022―Nov―10 |
Topical antibiotic therapy for perforated otitis in the COVID-19 pandemic |
S. V. Ryazantsev, K. A. Balatskaya, I. V. Tkachuk, A. E. Golovanov, P. V. Kireev |
| 58 |
[GO] |
2022―Oct―18 |
Prospects for studying the role of some essential and toxic trace elements in the pathogenesis of COVID-19 |
M. M. Sharipova, A. O. Romanov, M. V. Ivkina, A. N. Arkhangelskaia, K. G. Gurevich |
| 59 |
[GO] |
2022―Oct―18 |
Correct treatment regimen and inhalation technique are the components of success in bronchial asthma in the era of COVID-19 |
Yu. G. Belotserkovskaya, A. G. Romanovskikh, I. P. Smirnov |
| 60 |
[GO] |
2022―Oct―18 |
Functional and quantitative computed tomographic changes in the bronchopulmonary system in patients who have undergone COVID-19 |
A. V. Cherniak, N. A. Karchevskaya, I. M. Skorobogach, O. V. Leshchinskaya, E. N. Kalmanova, K. A. Zykov, S. S. Petrikov |
| 61 |
[GO] |
2022―Oct―18 |
Features of laboratory parameters in the new coronavirus infection COVID-19 against the background of diabetes mellitus and chronic heart failure |
E. Yu. Plotnikova, M. A. Sinkov, L. K. Isakov, M. N. Sinkova, A. Yu. Tarasova, V. N. Zolotukhina |
| 62 |
[GO] |
2022―Oct―18 |
COVID-19 and lung damage in obese patients: results of a prospective study |
A. V. Buchneva, N. V. Chichkova, E. V. Fominykh, N. V. Krupochkina, V. V. Fomin |
| 63 |
[GO] |
2022―Oct―18 |
New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions |
D. I. Trukhan |
| 64 |
[GO] |
2022―Oct―07 |
Evaluation of the efficacy and safety of remdesivir in hospitalized patients with a new coronavirus infection COVID-19: data from a Russian university clinic |
O. O. Yanushevich, I. V. Maev, N. I. Krikheli, O. V. Levchenko, D. N. Andreev, P. S. Sokolov, A. K. Fomenko, M. K. Devkota, N. G. Andreev, A. V. Zaborovsky, D. I. Shefer |
| 65 |
[GO] |
2022―Oct―07 |
Nutrition of elderly persons during a new coronavirus infection |
S. A. Solgalova, S. G. Kechedzhieva |
| 66 |
[GO] |
2022―Aug―15 |
Рrognostic value of proadrenomedullin in patients with COVID-19 |
A. A. Astapovskii, V. N. Drozdov, E. V. Shikh, N. B. Lazareva, S. Yu. Serebrova |
| 67 |
[GO] |
2022―Aug―15 |
Therapy experience in alopecia after COVID-19 |
O. A. Katkhanova, M. V. Golubchenko |
| 68 |
[GO] |
2022―Aug―15 |
The effect of a new coronavirus infection caused by the SARS-CoV-2 virus on microcirculation in the conjunctiva |
T. N. Safonova, G. V. Zaitseva, N. P. Kintyukhina |
| 69 |
[GO] |
2022―Aug―10 |
Coronavirus infection and psoriasis: relationship and consequences |
K. V. Katkova, E. V. Denisova, A. G. Soboleva, E. A. Pechatnikova, O. V. Zhukova, V. V. Sobolev, I. M. Korsunskaya |
| 70 |
[GO] |
2022―Jul―14 |
New devices to control fever in children with COVID-19 and other acute respiratory infections |
I. N. Zakharova, I. M. Osmanov, I. V. Berezhnaya, N. G. Sugian, I. D. Maykova, E. R. Samitova, D. S. Kolushkin, V. V. Pupykina, I. E. Rodionov |
| 71 |
[GO] |
2022―Jul―07 |
Interleukin-6 inhibitors: from the therapy of immuno-inflammatory rheumatic diseases to use in COVID-19 |
N. V. Muravyeva, B. S. Belov |
| 72 |
[GO] |
2022―Jul―07 |
Colchicine for the treatment of COVID-19: short path from theory to practice |
M. S. Eliseev, O. V. Zheliabina |
| 73 |
[GO] |
2022―May―17 |
Evaluation of the efficacy and safety of the 7% hypertonic solution with hyaluronic acid in patients with COVID-19 in the outpatient phase |
G. S. Anikin, I. V. Stozhkova, S. S. Sharonova, E. V. Kurdyukova |
| 74 |
[GO] |
2022―May―17 |
The use of intranasal glucocorticosteroids in the treatment of persistent allergic rhinitis after COVID-19 infection |
T. Yu. Vladimirova, A. M. Popova, M. N. Popov |
| 75 |
[GO] |
2022―May―17 |
Features of the treatment of acute otitis media in the COVID-19 pandemic |
S. V. Ryazantsev, I. V. Tkachuk, А. E. Golovanov, P. V. Kireev, K. A. Balatskaya, O. S. Donskaya |
| 76 |
[GO] |
2022―Apr―28 |
Features of the course of COVID-19 in patients with comorbid pathology |
M. M. Sharipova, M. V. Ivkina, A. N. Arkhangelskaia, K. G. Gurevich, I. V. Maev |
| 77 |
[GO] |
2022―Apr―28 |
Prospects for finding means of non-specific prevention of COVID-19 infection |
D. V. Usenko |
| 78 |
[GO] |
2022―Apr―28 |
New opportunities in the treatment of asthenic symptoms after a new coronavirus infection |
V. N. Shishkova, A. I. Martynov |
| 79 |
[GO] |
2022―Apr―08 |
Astenic syndrome in you students with different online-behaviors during the pandemic of new coronavirus infection COVID-19 |
L. S. Evert, N. Yu. Grishkevich, Yu. R. Kostyuchenko, S. S. Seren-ool, S. A. Bakhshieva |
| 80 |
[GO] |
2022―Apr―08 |
Factors affecting the content of Ig G-antibodies to S-protein SARS-CoV-2 in the blood of reconvalescents after new coronaviral infection (COVID-19) |
E. V. Kryukov, V. V. Salukhov, B. N. Kotiv, D. V. Ovchinnikov, Yu. V. Andreychuk, D. G. Denisov, A. B. Bogomolov, M. A. Kharitonov, Yu. V. Rudakov, P. S. Sadovnikov, A. A. Chugunov |
| 81 |
[GO] |
2022―Apr―08 |
Possibilities of information systems for prediction of outcomes of new coronavirus infection COVID-19 |
I. V. Demko, E. E. Korchagin, O. A. Cherkashin, N. V. Gordeeva, D. A. Anikin, D. A. Anikina |
| 82 |
[GO] |
2022―Apr―08 |
Surfactant therapy for pneumonia COVID-19 of obstetric patients |
M. V. Shvechkova, I. I. Kukarskaya, A. E. Bautin, T. V. Legalova, R. N. Marchenko, A. S. Shvechkova, E. Yu. Kukarskaya, E. A. Yakovleva |
| 83 |
[GO] |
2022―Apr―08 |
Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia |
M. V. Ezhov, T. E. Kolmakova, M. M. Matveeva, I. A. Alekseeva |
| 84 |
[GO] |
2022―Mar―14 |
Psychiatric and neurological aspects of sleep disturbance after coronavirus infection (COVID-19) |
E. D. Spektor, M. G. Poluektov |
| 85 |
[GO] |
2022―Mar―14 |
Cognitive impairment in hospitalized patients with COVID-19 |
S. P. Bordovsky, K. D. Tolmachev, K. K. Kriukova, O. I. Gurina, I. S. Preobrazhenskaya |
| 86 |
[GO] |
2022―Mar―07 |
COVID-19 pandemic and kidney disease in children: literature review and own regional observations |
O. V. Borisova, G. A. Makovetskaya, L. I. Mazur, N. M. Bochkareva, V. N. Barinov, O. N. Yashkina, S. A. Kolesnikov, S. N. Reshetova |
| 87 |
[GO] |
2022―Jan―11 |
Results of the non-interventional observational program: Influence of Novel COroNavirus on the condition of patients with liver and gastrointestinal Tract diseases and the effect of Ursodeoxycholic acid drugs and Rebamipide on the course of COVID-19 infection (CONTUR) |
I. N. Tikhonov, V. T. Ivashkin, M. S. Zharkova, M. V. Maevskaya, S. N. Koloteeva, A. S. Sarsenbaeva, L I. Tkachenko, O. V. Aronova, E. K. Tsvetaeva, N I. Trofimovskaya |
| 88 |
[GO] |
2022―Jan―11 |
Probiotics: relevant during the coronavirus (COVID-19) infection pandemic? |
M. A. Shevyakov |
| 89 |
[GO] |
2021―Dec―01 |
Possibilities of correction of post viral other dysfunction in the application of COVID-19 |
T. Yu. Vladimirova, L. A. Baryshevskaya, A. V. Kurenkov |
| 90 |
[GO] |
2021―Dec―01 |
Clinical case of COVID-19 in a patient treated with alemtuzumab |
E. V. Popova |
| 91 |
[GO] |
2021―Dec―01 |
Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
V. A. Golovacheva, A. A. Golovacheva |
| 92 |
[GO] |
2021―Dec―01 |
Role of etiotropic therapy in the treatment and prevention of influenza complications amidst the COVID-19 pandemic |
N. V. Orlova, V. V. Lomaychikov |
| 93 |
[GO] |
2021―Nov―02 |
Immunoprophylaxis of influenza, acute and recurrent respiratory infections during the COVID-19 pandemic |
A. A. Girina, A. L. Zaplatnikov, E. I. Burtseva, V. I. Svintsitskaya, I. D. Maykova, N. F. Dubovets, N. V. Koroid, I. V. Lepiseva, A. Е. Voskanyan, D. N. Tkacheva, A. D. Panova, S. A. Motorny |
| 94 |
[GO] |
2021―Nov―01 |
Influenza in the COVID-19 era: principles of modern pharmacotherapy |
N. B. Lazareva |
| 95 |
[GO] |
2021―Nov―01 |
Analysis of the antibiotic consumption on the backdrop of the COVID-19 pandemic: hospital level |
K. I. Karnoukh, N. B. Lazareva |
| 96 |
[GO] |
2021―Nov―01 |
Clinical case of nebulized surfactant therapy for severe COVID-19-associated pneumonia at the 2nd stage of rehabilitation treatment |
I. Yu. Stulikova, A. V. Tsvetkova, E. S. Koneva, T. V. Shapovalenko |
| 97 |
[GO] |
2021―Nov―01 |
Optimization of therapy of patients with bronchial asthma in conditions of coronavirus infection |
E. M. Kostina, E. Yu. Trushina, E. A. Orlova |
| 98 |
[GO] |
2021―Nov―01 |
The effectiveness of combination of 7% hypertonic saline and 0.1% natrii hyaluronas in patients with chronic obstructive pulmonary disease who have suffered a new coronavirus infection |
O. N. Titova, N. A. Kuzubova, D. B. Skliarova, A. L. Aleksandrov, N. V. Egorova |
| 99 |
[GO] |
2021―Nov―01 |
Coronavirus pneumonia in kidney transplant recipients: current evidence from own clinical experience |
I. V. Lekareva, A. L. Emelianova, E. V. Kalinina, A. R. Babaeva, E. V. Scherbinina |
| 100 |
[GO] |
2021―Oct―20 |
Liver drug damage: possibilities of polyionic succinate-methioninic complex during the pandemic of new coronavirus infection (COVID-19) |
D. I. Trukhan, E. L. Davydov |
| 101 |
[GO] |
2021―Oct―18 |
The recovery of endothelial function in novel coronavirus infection COVID-19 (review) |
E. V. Roitman |
| 102 |
[GO] |
2021―Oct―17 |
The use of combined hormonal contraception in the context of the COVID-19 pandemic |
A. T. Uruymagova, V. N. Prilepskaya, E. A. Mezhevitinova, M. T. Poghosyan |
| 103 |
[GO] |
2021―Oct―17 |
Recurrent vulvovaginal candidiasis during COVID-19 pandemic: medical algorithm |
N. M. Nazarova, K. I. Gusakov, S. V. Pavlovich, E. R. Dovletkhanova |
| 104 |
[GO] |
2021―Sep―20 |
Possibilities of daytime anxolytics in the correction of residual neurological manifestations of COVID-19 |
E. A. Alexandrova, E. V. Parshina, I. V. Borodacheva, A. G. Suslov, K. M. Beliakov, V. S. Yulin, S. V. Fomin |
| 105 |
[GO] |
2021―Sep―20 |
Pathogenetic bases of the use of antifibrotic therapy with Bovhyaluronidazum azoximerum in patients with new coronavirus infection COVID-19 |
O. A. Chernyavskaya, A. V. Osipov |
| 106 |
[GO] |
2021―Sep―20 |
The role and place of glucocorticosteroids in treatment of COVID-19 pneumonia without hypoxemia |
V. V. Salukhov, E. V. Kryukov, A. A. Chugunov, M. A. Kharitonov, Yu. V. Rudakov, R. E. Lakhin, V. V. Dancev, I. A. Stepanenko, M. O. Gurba, T. V. Stepanova, A. V. Bolekhan, L. H. Arzhavkina |
| 107 |
[GO] |
2021―Sep―20 |
Safety and efficacy of acetylsalicylic acid in the secondary prevention of cardiovascular diseases in combination with comorbid diseases. COVID-19 treatment options |
O. A. Tsvetkova, O. O. Voronkova |
| 108 |
[GO] |
2021―Sep―20 |
Influence of coronavirus infection on the course of psoriasis |
K. V. Katkova, K. T. Plieva, E. V. Denisova, O. V. Zhukova, A. V. Volnukhin, I. M. Korsunskaya |
| 109 |
[GO] |
2021―Sep―20 |
Differential diagnosis of myocardial infarction and myopericarditis during a pandemic |
E. V. Konstantinova, M. R. Atabegashvili, A. A. Savicheva, A. P. Nesterov, M. Yu. Gilyarov |
| 110 |
[GO] |
2021―Aug―12 |
Clinical observation of the course of COVID-19 in patients with multiple sclerosis during ocrelizumab therapy: two clinical cases |
E. V. Popova, M. I. Alexandrov, I. A. Trubnikova, S. R. Zeynalova |
| 111 |
[GO] |
2021―Aug―12 |
Preventive vaccination compliance among medical students and pediatricians during the COVID-19 pandemic |
A. V. Dmitriev, N. V. Fedinа, T. G. Tkachenko, R. A. Gudkov, V. I. Petrova, А. L. Zaplatnikov |
| 112 |
[GO] |
2021―Aug―12 |
Antirheumatic drugs and COVID-19: frustrations and hopes |
E. S. Aronova, B. S. Belov |
| 113 |
[GO] |
2021―Aug―12 |
Modern approaches to the diagnosis and treatment of anxiety disorders associated with a new coronavirus infection |
P. V. Aronov, G. N. Belskaya, I. A. Nikiforov |
| 114 |
[GO] |
2021―Aug―12 |
Motor-speech disorders in a patient with a vertebrobasilar stroke affected by coronavirus infection (clinical observation) |
A. V. Obukhova, N. N. Koberskaya, D. A. Artemev |
| 115 |
[GO] |
2021―Aug―08 |
Limitations and opportunities of cancer treatment in the COVID-19 pandemic |
R. V. Orlova, E. A. Kaledina, A. M. Malkova, N. V. Zhukova, P. A. Naymushina, N. P. Beliak, A. E. Jukova, A. S. Sarmatova, N. A. Karaseva, I. V. Egorova, K. N. Teslenko, A. V. Tarasov |
| 116 |
[GO] |
2021―Jun―08 |
Hair loss due to a new coronavirus infection: treatment approaches |
L. R. Sakania, O. O. Melnichenko, I. M. Korsunskaya |
| 117 |
[GO] |
2021―May―13 |
Case of severe liver damage in COVID-19 |
E. Yu. Plotnikova, E. N. Baranova, M. S. Karyagina, O. A. Vorosova, K. A. Krasnov |
| 118 |
[GO] |
2021―May―13 |
Preventive and therapeutic role of nasal irrigation in management of acute respiratory disease during COVID-19 pandemic and beyond |
V. M. Svistushkin, Zh. T. Mokoyan |
| 119 |
[GO] |
2021―May―13 |
Obesity, non-alcoholic fatty liver disease, COVID-19: dangerous liaisons |
S. V. Tikhonov, V. D. Dekkanova, S. A. Vinnichuk, T. S. Fil, N. V. Bakulina |
| 120 |
[GO] |
2021―Apr―21 |
Innovative methods of rehabilitation at the outpatient and homestages in patients after pneumonia COVID-19 |
T. L. Alenskaya |
| 121 |
[GO] |
2021―Apr―21 |
Nutritional problems of patients infected with COVID-19 and potential for nutritional management of disorders |
T. L. Pilat, S. N. Alekseenko, V. A. Krutova, M. Yu. Akimov, I. V. Radysh, T. N. Umnova, A. V. Istomin, E. A. Gordeeva, M. M. Korosteleva, R. A. Khanferyan |
| 122 |
[GO] |
2021―Apr―21 |
Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system |
S. G. Kanorskiy |
| 123 |
[GO] |
2021―Apr―21 |
Cognitive impairment in COVID-19 survivors |
N. V. Pizova, N. A. Pizov, A. V. Pizov |
| 124 |
[GO] |
2021―Apr―21 |
The effect of renin-angiotensin-aldosterone blockers on SARS-CoV-2 infection in adults: a systematic review of studies and meta-analyzes |
М. V. Leonova |
| 125 |
[GO] |
2021―Mar―22 |
Modern opportunities of interferons in treatment of children with COVID-19 |
Asiya I. Safina, Olga V. Sharipova, Ildus Ya. Lutfullin, Olga S. Naumova, Maria A. Daminova |
| 126 |
[GO] |
2021―Mar―22 |
Community-acquired pneumonia in children in the era of the COVID-19 pandemic. What has changed? |
Olga V. Zaytseva, Svetlana V. Zaytseva, Evelina E. Lokshina, Dmitriy V. Khaspekov, Nadezhda V. Tkachenko, Natalya A. Sholokhova, Elena V. Kulikova, Khilda Yu. Simonovskaya, Anna Yu. Tomilova, Adam T. Barkinkhoev, Tatyana Yu. Belyaeva |
| 127 |
[GO] |
2021―Jan―18 |
Topical issues of diagnostics, examination and treatment of patients with COVID-19-associated pneumonia in different countries and continents |
V. V. Salukhov, M. A. Kharitonov, E. V. Kryukov, T. V. Stepanova, A. V. Nikolaev, Yu. V. Rudakov, A. B. Bogomolov, A. A. Chugunov |
| 128 |
[GO] |
2021―Jan―18 |
Vitamin D is a strategic blow to coronavirus infection |
V. V. Salukhov, E. A. Kovalevskaya |
| 129 |
[GO] |
2020―Nov―29 |
Effectiveness of pathogenetic therapy for infectious diarrhea in children with COVID-19 |
D. A. Khavkina, T. A. Ruzhentsova, R. V. Popova, P. V. Chukhlyaev, A. A. Garbuzov, N. A. Meshkova |
| 130 |
[GO] |
2020―Nov―29 |
Risks and control of bronchial asthma in children in conditions of COVID-19 pandemic |
Article Editorial |
| 131 |
[GO] |
2020―Nov―23 |
Antagonism between pneumococcal vaccines and COVID-19 |
A. M. Kostinov, M. P. Kostinov, C. V. Mashilov |
| 132 |
[GO] |
2020―Nov―23 |
Predicting the duration of inpatient treatment for COVID-19 patients |
V. V. Tsvetkov, I. I. Tokin, D. A. Lioznov, E. V. Venev, A. N. Kulikov |
| 133 |
[GO] |
2020―Nov―23 |
Inhaled surfactant in patients with covid-19 who took high-flow oxygen: the results of a retrospective analysis |
A. V. Averyanov, T. V. Klypa, O. I. Balionis, M. V. Bychinin, A. V. Cherniak, A. V. Troitskiy, E. V. Trifonova |
| 134 |
[GO] |
2020―Nov―23 |
Allergic rhinitis during a coronavirus pandemic: difficulties of diagnosis and features of therapy |
O. V. Sebekina, E. V. Peredkova, N. M. Nenasheva, Yu. V. Grebennikova |
| 135 |
[GO] |
2020―Nov―16 |
Experience in managing psoriasis patients receiving targeted therapy during the COVID-19 pandemic |
N. N. Potekaev, O. V. Zhukova, S. I. Artemyeva, M. N. Ostretsova |
| 136 |
[GO] |
2020―Oct―23 |
Dietary management of digestive and gastrointestinal disorders after long-term self-isolation and lockdown as well as patients with SARS-CoV-2 during the rehabilitation period |
T. L. Pilat, I. V. Radysh, V. V. Surovtsev, M. M. Korosteleva, R. A. Khanferyan |
| 137 |
[GO] |
2020―Oct―21 |
Effectiveness of pathogenetic therapy for infectious diarrhea in children with COVID-19 |
D. A. Khavkina, T. A. Ruzhentsova, R. V. Popova, P. V. Chukhliaev, A. A. Garbuzov, N. A. Meshkova |
| 138 |
[GO] |
2020―Oct―15 |
Male infertility: before and after the era of SARS-CoV-2 |
R. I. Ovchinnikov, S. I. Gamidov, A. Yu. Popova, S. Kh. Izhbaev |
| 139 |
[GO] |
2020―Aug―08 |
Capabilities of mobile health to treat diabetes in the conditions of the COVID-19 pandemic |
L. L. Bolotskaya |
| 140 |
[GO] |
2020―Jul―30 |
Practical recommendation for treatment of patients with colon cancer during covid-19 pandemic |
M. Yu. Fedyanin |
| 141 |
[GO] |
2020―Jul―30 |
Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic |
V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi |
| 142 |
[GO] |
2020―Jul―16 |
COVID-19 and Rheumatology: so far, so close |
B. S. Belov, N. M. Muravyeva, G. M. Tarasova |
| 143 |
[GO] |
2020―Jul―16 |
Acute cerebral circulatory disorders and coronavirus disease |
N. V. Pizova, N. A. Pizov, O. A. Skachkova, M. A. Sokolov, I. A. Izmaylov, R. B. Taramakin |
